Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NUS researchers develop an innovative and flexible method to study immune cell capabilities 2023-12-18 14:47
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) 2023-12-18 09:49
GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics 2023-12-18 09:43
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM 2023-12-17 23:15
Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction 2023-12-16 15:47
Ubie Won the "Best with AI" in Google Play Best of 2023 (Japan) 2023-12-16 00:00
Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023 2023-12-15 21:00
SeekIn and OncoInv Collaborate to Expand the Global Accessibility of Multiple Cancer Detection Tests and Bridge Global Disparities in Cancer Care 2023-12-15 21:00
Live from ASH 2023 | Oral Report Featuring Encouraging Data of Olverembatinib Combined with Reduced-Intensity Chemotherapy in Patients with Ph+ ALL Presented at the ASH Annual Meeting 2023-12-15 11:14
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033, an MSLN-Targeted Antibody-Drug Conjugate (ADC) 2023-12-15 07:30
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed 2023-12-14 22:05
China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement 2023-12-14 21:30
Titans Gather, Future Embarks: The GenScript Biotech Global Forum coinciding with the 2024 J.P. Morgan Healthcare Conference in San Francisco to Convene 20+ KOLs, Exploring Disruptive Transformations and Infinite Opportunities in GCT 2023-12-14 20:34
Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs 2023-12-14 17:00
Abbisko Therapeutics Announces that U.S. FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021) 2023-12-14 08:30
WAT Medical Joins World's Largest Boat Show 2023-12-13 22:00
Virtual twin to improve treatment with cancer immunotherapies 2023-12-13 21:06
Alebund Reports Update for AP306 (EOS789), a First-in-Class Pan-inhibitor of Sodium-dependent Phosphate Transporters, from a Completed Phase II Clinical Trial in Patients with Hyperphosphatemia on Hemodialysis 2023-12-13 21:00
Dizal's Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine 2023-12-13 18:00
Live from ASH 2023 | Results from Chinese Studies of Olverembatinib Presented in Oral Report at the ASH Annual Meeting for the Sixth Consecutive Year, Including Data Showing Promising Efficacy in Patients with TKI-Resistant and/or Intolerant CML-CP 2023-12-13 16:47
1 57 58 59 60 61 800